187 related articles for article (PubMed ID: 16100492)
1. Focal nodular hyperplasia (FNH): a potential cause of false-positive positron emission tomography.
Aznar DL; Ojeda R; Garcia EU; Aparici F; Sánchez PA; Flores D; Martínez C; Sopena R
Clin Nucl Med; 2005 Sep; 30(9):636-7. PubMed ID: 16100492
[TBL] [Abstract][Full Text] [Related]
2. 18F-fluorodeoxyglucose (FDG)-PET features of focal nodular hyperplasia (FNH) of the liver.
Kurtaran A; Becherer A; Pfeffel F; Müller C; Traub T; Schmaljohann J; Kaserer K; Raderer M; Schima W; Dudczak R; Kletter K; Virgolini I
Liver; 2000 Dec; 20(6):487-90. PubMed ID: 11169064
[TBL] [Abstract][Full Text] [Related]
3. C-11 acetate does not enhance usefulness of F-18 FDG PET/CT in differentiating between focal nodular hyperplasia and hepatic adenoma.
Magini G; Farsad M; Frigerio M; Serra C; Colecchia A; Jovine E; Vivarelli M; Feletti V; Golfieri R; Patti C; Fanti S; Franchi R; Lodi F; Boschi S; Bernardi M; Trevisani F
Clin Nucl Med; 2009 Oct; 34(10):659-65. PubMed ID: 19893396
[TBL] [Abstract][Full Text] [Related]
4. Two cases of focal nodular hyperplasia of the liver: value of scintigraphy with Tc-99m GSA and positron emission tomography with FDG.
Shiomi S; Kurooka H; Iwata Y; Sasaki N; Masaki K; Jomura H; Nishiguchi S; Kuroki T; Ochi H
Ann Nucl Med; 1999 Dec; 13(6):427-31. PubMed ID: 10656279
[TBL] [Abstract][Full Text] [Related]
5. The use of 18F-fluoromethylcholine PET/CT in differentiating focal nodular hyperplasia from hepatocellular adenoma: a prospective study of diagnostic accuracy.
Bieze M; Bennink RJ; El-Massoudi Y; Phoa SS; Verheij J; Beuers U; van Gulik TM
Nucl Med Commun; 2013 Feb; 34(2):146-54. PubMed ID: 23154640
[TBL] [Abstract][Full Text] [Related]
6. Incremental diagnostic value of F-18 FDG PET/CT over MRI in a pediatric patient with suspected hepatoblastoma and histologic diagnosis of focal nodular hyperplasia.
Bertagna F; Orlando E; Bosio G; Bercich L; Fisogni S; Grazioli L; Giubbini R
Clin Nucl Med; 2011 Apr; 36(4):305-8. PubMed ID: 21368608
[No Abstract] [Full Text] [Related]
7. Clinical usefulness of positron emission tomography with fluorine-18-fluorodeoxyglucose in the diagnosis of liver tumors.
Iwata Y; Shiomi S; Sasaki N; Jomura H; Nishiguchi S; Seki S; Kawabe J; Ochi H
Ann Nucl Med; 2000 Apr; 14(2):121-6. PubMed ID: 10830530
[TBL] [Abstract][Full Text] [Related]
8. Differentiation of hepatocellular adenoma and focal nodular hyperplasia using 18F-fluorocholine PET/CT.
van den Esschert JW; Bieze M; Beuers UH; van Gulik TM; Bennink RJ
Eur J Nucl Med Mol Imaging; 2011 Mar; 38(3):436-40. PubMed ID: 20717825
[TBL] [Abstract][Full Text] [Related]
9. Distinction between hepatic focal nodular hyperplasia and malignant liver lesions using technetium-99m-galactosyl-neoglycoalbumin.
Kurtaran A; Müller C; Novacek G; Kaserer K; Mentes M; Raderer M; Pidlich J; Eibenberger K; Angelberger P; Virgolini I
J Nucl Med; 1997 Dec; 38(12):1912-5. PubMed ID: 9430468
[TBL] [Abstract][Full Text] [Related]
10. Dual time point C-11 acetate PET imaging can potentially distinguish focal nodular hyperplasia from primary hepatocellular carcinoma.
Huo L; Wu Z; Zhuang H; Fu Z; Dang Y
Clin Nucl Med; 2009 Dec; 34(12):874-7. PubMed ID: 20139820
[TBL] [Abstract][Full Text] [Related]
11. 11C-acetate PET imaging in hepatocellular carcinoma and other liver masses.
Ho CL; Yu SC; Yeung DW
J Nucl Med; 2003 Feb; 44(2):213-21. PubMed ID: 12571212
[TBL] [Abstract][Full Text] [Related]
12. Variable uptake feature of focal nodular hyperplasia in Tc-99m phytate hepatic scintigraphy/single-photon emission computed tomography-A parametric analysis.
Hsu YL; Chen YW; Lin CY; Lai YC; Chen SC; Lin ZY
Kaohsiung J Med Sci; 2015 Dec; 31(12):621-5. PubMed ID: 26709223
[TBL] [Abstract][Full Text] [Related]
13. Early dynamic F18-FDG-PET shows a hypervascular pattern with central scar in a liver mass.
Schierz JH; Lopatta E; Settmacher U; Freesmeyer M
Liver Int; 2012 Oct; 32(9):1372. PubMed ID: 22882619
[No Abstract] [Full Text] [Related]
14. Imaging modalities for focal nodular hyperplasia and hepatocellular adenoma.
van den Esschert JW; van Gulik TM; Phoa SS
Dig Surg; 2010; 27(1):46-55. PubMed ID: 20357451
[TBL] [Abstract][Full Text] [Related]
15. Focal nodular hyperplasia or focal nodular hyperplasia-like lesions of the liver: a special emphasis on diagnosis.
Choi JY; Lee HC; Yim JH; Shim JH; Lim YS; Shin YM; Yu ES; Suh DJ
J Gastroenterol Hepatol; 2011 Jun; 26(6):1004-9. PubMed ID: 21251063
[TBL] [Abstract][Full Text] [Related]
16. Hepatocellular adenoma and focal nodular hyperplasia: a series of 24 patients with clinicopathological and radiological correlation.
Ji Y; Zhu X; Sun H; Tan Y; Ma Z; Ye Q; Sujie A; Tang Z
Chin Med J (Engl); 2000 Sep; 113(9):852-7. PubMed ID: 11776086
[TBL] [Abstract][Full Text] [Related]
17. Efficacy comparison of multi-phase CT and hepatotropic contrast-enhanced MRI in the differential diagnosis of focal nodular hyperplasia: a prospective cohort study.
Nowicki TK; Markiet K; Izycka-Swieszewska E; Dziadziuszko K; Studniarek M; Szurowska E
BMC Gastroenterol; 2018 Jan; 18(1):10. PubMed ID: 29334905
[TBL] [Abstract][Full Text] [Related]
18. Pure ground glass nodular adenocarcinomas: Are preoperative positron emission tomography/computed tomography and brain magnetic resonance imaging useful or necessary?
Cho H; Lee HY; Kim J; Kim HK; Choi JY; Um SW; Lee KS
J Thorac Cardiovasc Surg; 2015 Sep; 150(3):514-20. PubMed ID: 26189165
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of benign vs malignant hepatic lesions with positron emission tomography.
Delbeke D; Martin WH; Sandler MP; Chapman WC; Wright JK; Pinson CW
Arch Surg; 1998 May; 133(5):510-5; discussion 515-6. PubMed ID: 9605913
[TBL] [Abstract][Full Text] [Related]
20. Hepatic adenoma mimicking a metastatic lesion on computed tomography-positron emission tomography scan.
Lim D; Lee SY; Lim KH; Chan CY
World J Gastroenterol; 2013 Jul; 19(27):4432-6. PubMed ID: 23885159
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
